IntelGenX
Saint Laurent
About IntelGenX
IntelGenx is an oral drug delivery company primarily focused on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. It provides comprehensive pharmaceutical services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP, and regulatory services. IntelGenx’s state-of-the-art manufacturing facility, established for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, offering full-service capabilities to its clients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $38.8M
- Funding stage: M&A
- Last round: Post-IPO Equity (Aug 2023)
- Ticker: otcqx:IGXT
- Website: intelgenx.com
- Phone: (514)331-7440
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/intelgenx-213169 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.